在乳腺癌中以基因组分析为指导的精密瘤学:来自分子瘤板的真实世界数据
Tim Graf1,2, Laura A Boos1,2, Tarun Mehra1
1Department of Medical Oncology and Hematology, University Hospital Zurich, 8091 Zurich, Switzerland.
Cancers
|August 14, 2025
概括
基因组分析和分子瘤板 (MTBs) 帮助晚期乳腺癌 (BC) 患者获得向治疗. 大约一半接受分子向治疗 (MTT) 的患者表现出临床益处,突出了改善治疗的必要性.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 临床实践 临床实践
背景情况:
- 基因组分析 (GP) 越来越多地用于晚期乳腺癌 (BC).
- 基于生物标志物的疗法使治疗决策复杂化,使分子瘤板 (MTB) 变得至关重要.
- 在先进的BC中,MTB实用性的真实数据有限.
研究的目的:
- 评估分子发现的转化为BC患者的MTB建议.
- 检查在临床实践中MTB建议的实施和结果.
主要方法:
- 对103名接受GP治疗的晚期BC患者进行了回顾性单中心研究 (2018年1月至2023年12月).
- 在每周的多学科MTB中讨论的患者.
- 数据包括GP结果,MTB建议和治疗结果 (MTT接收,最佳反应).
主要成果:
- 经过MTB检查94名患者,对68名患者 (72.3%) 发布了155条建议.
- 63名患者 (67%) 接受了治疗建议,其中38名 (60.3%) 接受了分子向治疗 (MTT).
- 在35名可评估患者中,16名 (45.7%) 显示MTT具有临床益处.
结论:
- 全科医生和MTB扩大了高级BC的生物标志物匹配治疗选择.
- 大约一半接受MTT治疗的患者经历了临床益处.
- 标准化,多生物标志物预测和改善MTT交付是未来的关键挑战.
关键词:
乳腺癌 乳腺癌 乳腺癌基因组特征分析 (genomic profiling) 是一种基因组特征.匹配的有针对性的治疗方法.分子瘤板是一个分子瘤板.这是下一代测序.精确瘤学 精确瘤学现实世界的证据.更多相关视频
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.5K
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
